Pharmaceutical

Defence Therapeutics Key Platform Patent Accepted Broadly Covering Vaccine Technology

Vancouver, British Columbia--(Newsfile Corp. - November 7, 2023) -  Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or…

1 year ago

Nomination Committee Appointed for IRLAB’s Annual General Meeting 2024

GOTHENBURG, SE / ACCESSWIRE / November 07, 2023 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, November 7, 2023 - IRLAB…

1 year ago

Brad Burton PharmD, Highlights Traineeship Program for Practicing Pharmacy Professionals

CHAPEL HILL, NC / ACCESSWIRE / November 6, 2023 / Renowned clinical pharmacy specialist, Dr. Brad Burton is extending his…

1 year ago

FSD Pharma Files Preliminary Base Shelf Prospectus to Replace Expired Base Shelf Prospectus

TORONTO, ON / ACCESSWIRE / November 6, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical…

1 year ago

NeoGenomics Reports Third Quarter 2023 Results

Third Quarter Revenue Increased 18% to $152 MillionFORT MYERS, FL / ACCESSWIRE / November 6, 2023 / NeoGenomics, Inc. (NASDAQ:NEO)…

1 year ago

CMTA Appoints Biotech Industry Veteran Suzanne Bruhn, PhD as New CEO

GLENOLDEN, PA / ACCESSWIRE / November 6, 2023 / The Charcot-Marie-Tooth Association announced Nov. 6 that Suzanne (Sue) Bruhn, PhD,…

1 year ago

Nexcella Presents NXC-201 Data at 65th American Society of Hematology (ASH) Annual Meeting in 63 Relapsed/Refractory Multiple Myeloma Patients

95% overall response rate observed in relapsed/refractory multiple myeloma patients not previously treated with BCMA-targeted therapy98% overall response rate observed…

1 year ago

BioNxt Solutions Reports on Barcelona CPHI Conference

VANCOUVER, BC / ACCESSWIRE / November 6, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTFF)(FSE:BXT) is pleased to…

1 year ago